HomeOpen Access NewsScience & Research

Science & Research

€17.8 Million for transformative neighbourhood projects in New European Bauhaus initiative

The European Union has announced a significant funding opportunity for projects aimed at revitalizing neighbourhoods and fostering sustainability through the New European Bauhaus initiative.

IMPAQT: Supporting the sustainable development of aquaculture

Here, Coordinator of the Intelligent Management Systems for Integrated Multi-Trophic Aquaculture (IMPAQT) project Frank Kane discusses the path to revolutionising aquaculture and increasing the industry’s sustainability.

SpiralG Project: The first demonstrator of spirulina biorefinery

Here, we learn about the many uses of spirulina algae, and how BBI JU funded project SpiralG is assessing the sustainability and profitability of each spirulina biomass component.

Infrastructure and jobs for energy and mobility

Prof Dr Michael Düren from Justus Liebig University Giessen shares his expertise on infrastructure and jobs for both energy and mobility.

Bharat Biotech COVID vaccine shows 81% efficacy at Phase Three

The Bharat Biotech COVID vaccine, COVAXIN, appears to be 81% efficient against the virus in Phase Three of clinical trials.

Are swollen lymph nodes normal after getting the COVID vaccine?

According to radiologists at Massachusetts General Hospital (MGH), swollen lymph nodes after COVID vaccination are a "normal reaction that typically goes away with time".

Japanese scientists are creating realistic steak meat in a petri dish

A team at the University of Tokyo are creating steak meat in a petri dish, which could soon become the most realistic tasting biosynthetic meat available.

The AstraZeneca vaccine is atleast 60% effective for people aged 70 and over

A study examining older people in the UK found that only one dose of the AstraZeneca vaccine is atleast 60% effective for people aged 70 and over.

FDA approves the Johnson & Johnson vaccine for use

The US Food and Drug Administration (FDA) approved the Johnson & Johnson vaccine, with an efficacy of 86%, as the next to be rolled out across the US.

The Brazilian COVID mutation has been found in the UK

The UK has found six confirmed cases of the Brazilian COVID mutation yesterday (28 February) - but an individual who tested positive three weeks ago is still being traced throughout the country.

45% of people living with obesity have healthy blood pressure

Scientists have discovered that up to 45% of people living with obesity have healthy blood pressure, glucose and lipid levels - protecting them from the risk of cardiovascular disease.

The window for convalescent plasma donation is just under two months

New data suggests that before 60 days of COVID symptoms beginning is the best window for convalescent plasma donation - which is how antibodies were created in countless COVID-19 patients before vaccines.

What are the priority groups for phase two of UK vaccinations?

The Government unveiled the confirmed priority groups for phase two of UK vaccinations - the Joint Committee on Vaccination and Immunisation (JCVI) is choosing age as the deciding factor.

1.17 million doses of the AstraZeneca vaccine could expire in Germany

Germans have only taken 270,986 AstraZeneca doses so far, leaving roughly 1.17 million doses in storage across the country - but these shots are due to expire in less than six months.

UK Government report finds “alarming” COVID impact in South Asians

The first wave saw minority ethnicities hit harder than white people, but in the second wave things are improving - with the exception of an "alarming" COVID impact in South Asians, specifically Bangladeshis and Pakistanis.

Scientists calculate the impact of wildfires on global ecosystems

After going through decades' worth of data, scientists at the University of Cambridge explain the impact of wildfires on global ecosystems - from carbon dioxide emissions to the resilience of trees.

The Pfizer vaccine is stopping 92% of severe COVID cases in Israel

Israel is currently leading the world in COVID vaccination, with real-world data to suggest that the Pfizer vaccine is working to stop 92% of severe COVID cases.

Advertisements


Latest Academic Articles

The latest academic articles from key research stakeholders